SGHT · Sight Sciences, Inc. · Metrics
Market Cap
$448.42M
Shares
55.09M
SGHT metrics
70 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$8.14
Market cap
$448.42M
Price action
20 metricsPrice change (1W)
-4.5%
Price change (30D)
-3.8%
Price change (3M)
+67.1%
Price change (6M)
+121.1%
Price change (YTD)
+0.9%
Price change (1Y)
+134.8%
Trailing year
Price change (5Y)
-74.3%
52-week high
$9.05
52-week low
$3.20
Change from 52-week high
-11.5%
Change from 52-week low
+150.2%
Annualized volatility
84.1%
Annualized volatility (3M)
71.5%
Beta
1.9
RSI (14D)
56.5
Price vs SMA 50
+19.4%
Price vs SMA 200
+36.4%
Avg volume (3M)
224,927
Relative volume
0.8
Average dollar volume
$1.48M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
55.09M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.8×
reciprocal yield 20.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
5.3×
reciprocal yield 18.9%
P / book
8.3
reciprocal yield 12.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.1×
reciprocal yield 48.8%
EV / revenue historical average (5Y)
2.6×
reciprocal yield 38.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
88.0%
Operating margin
-33.4%
Trailing 12 months
Net margin
-35.7%
Gross profit (TTM)
$73.34M
Operating profit (TTM)
−$27.87M
Net income (TTM)
−$29.76M
Trailing 12 months
Diluted EPS (TTM)
$-0.55
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+19.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$83.38M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.2%
Year over year · more shares
Revenue CAGR (3Y)
+2.7%
Revenue CAGR (5Y)
+22.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-56.3%
Return on assets
-28.4%
Debt / equity
0.8
Current ratio
4.9
EBITDA (TTM)
−$27.46M
Free cash flow (TTM)
—
Quick ratio
4.7
Interest coverage
-5.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$38.98M
Latest balance sheet
Cash & equivalents
$79.75M
Total assets
$104.87M
Total debt
$40.78M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$23.24M
Capital expenditures (TTM)
$93,000
R&D (TTM)
$10.85M
SG&A (TTM)
$90.36M
Stock compensation (TTM)
$10.79M
R&D / revenue
13.0%
Stock compensation / revenue
12.9%
Ownership (13F)
3 metrics13F filers
111
13F filer change QoQ
-3
Institutional ownership
40.2%
Short interest
3 metricsShort interest
2.2%
Latest settlement · 5.5 days to cover
Days to cover
5.5d
Short-squeeze score
67 / 100
Insider activity
2 metricsNet insider buying (90D)
−$448,413
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1531177
CUSIP
82657M105
13F (30d)
41 filings
41 filers
Visit website
Investor relations